Table 5.
Univariate and multivariate analysis for complications and mortality
| Complication | Major complication | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| OR (95% CI) univariate | p | OR (95% CI) multivariate | p | OR (95%CI) univariate | p | OR (95%CI) univariate | p | |
| Age | 1.010 (0.974–1.046) | 0.594 | 0.959 (0.892–1.031) | 0.256 | 1.019 (0.931–1.115) | 0.69 | ||
| BMI | 0.968 (0.902–1.032) | 0.364 | 0.924 (0.784–1.089) | 0.347 | 0.842 (0.687–1.031) | 0.096 | ||
| hypotension | 7.843 (0.678–88.20) | 0.051 | 53.74 (4.45–649) | < 0.001 | 120 (8.95–1600) | < 0.001 | ||
| Tachycardia | 4.217 (1.41–12.74) | 0.006 | 2.889 (0.673–12.40) | 0.154 | 7.909 (1.84–33.98) | 0.001 | 23.1 (4.13–129) | < 0.001 |
| Mental impairment | 3.837 (1.277–11.529) | 0.011 | 2.502 (0.626–9.993) | 0.194 | 10 (2.57–38.88) | < 0.001 | 26.4 (5.192–134.226) | < 0.001 |
| Male Sex | 0.635 (0.349–1.155) | 0.135 | 1.018 (0.314–3.297) | 0.976 | 1.875 (0.357–9.854) | 0.451 | ||
| ASA ≥ 3 | 1.730 (0.916–3.265) | 0.089 | 1.407 (0.413–4.797) | 0.584 | 4.352 (0.516–36.70) | 0.141 | ||
| Charlson ≥ 6 | 2.09 (1.138–3.867) | 0.016 | 1.105 (0.624–1.956) | 0.732 | 3.150 (1.03–10.24) | 0.046 | – | < 0.001 |
| Crural hernia | 1.404 (0.750–2.630) | 0.287 | 1.147 (0.335–3.925) | 0.827 | 0.889 (0.169–4.687) | 0.89 | ||
| Laparotomy | 4.161 (2.166–7.995) | < 0.001 | 6.607 (2.905–15.03) | < 0.001 | 5.657 (1.722–18.586) | 0.002 | 5.2 (1.127–23.987) | 0.02 |
| Prosthesis | 0.795 (0.433–1.46) | 0.46 | 1.008 (0.285–3.571) | 0.99 | 1.034 (0.205–5.223) | 0.968 | ||
| Bowel resection | 3.448 (1.755–6.776) | < 0.001 | 0.721 (0.193–3.165) | 0.728 | 6.833 (2.069–22.567) | < 0.001 | 6.264 (1.353–29.005) | 0.008 |
| Arrhythmia | 2.074 (1.134–3.792) | 0.017 | 2.813 (1.317–6.008) | 0.008 | 1.224 (.0378–3.971) | 0.735 | 1.247 (0.273–5.698) | 0.775 |
| Ischemic heart disease | 2.296 (0.531–9.922) | 0.253 | 8.003 (1.437–44.897) | 0.005 | 15.933 (2.558–99.23) | < 0.001 | ||
| Chronic heart disease | 2.588 (0.704–9.516) | 0.139 | 11.429 (2.531–51.597) | < 0.001 | 11.850 (1.898–70.605) | 0.001 | ||
| Hypertension | 1.739 (0.890–3.397) | 0.103 | 2.767 (0.593–12.91) | 0.178 | 3.188 (0.378–26.91) | 0.261 | ||
| cerebrovascular disease | 1.181 (0.522–2.668) | 0.689 | 1.172 (0.247–5.572) | 0.841 | 2.322 (0.434–12.42) | 0.312 | ||
| Oral anticoagulants | 1.915 (0.966–3.795) | 0.06 | 3.04 (0.924–9.999) | 0.056 | 5.617 (1.216–25.95) | 0.014 | ||
| COPD | 2.205 (1.102–4.412) | 0.023 | 2.505 (1.024–6.126) | 0.044 | 3.389 (1.027–11.182) | 0.035 | 3.426 (0.74–15.855) | 0.095 |
| Metastatic solid tumors | 1.904 (0.461–7.87) | 0.366 | 2.716 (0.312–23.666) | 0.347 | 4.938 (0.53–45.972) | 0.121 | ||
| Non-metastatic solid tumors | 1.347 (0.504–3.598) | 0.551 | 2.152 (0.442–10.478) | 0.332 | 4.5 (0.82–24.692) | 0.059 | ||
| Liver disease | 0.401 (0.05–3.237) | 0.376 | – | 0.477 | – | 0.606 | ||
| Kidney disease | 1.838 (0.71–4.758) | 0.205 | 2.27 (0.465–11.082) | 0.298 | 4.5 (0.82–24.692) | 0.59 | ||
| Diabetes | 1.868 (0.895–3.898) | 0.093 | 1.778 (0.461–6.862) | 0.398 | 4.086 (0.879–18.98) | 0.053 | ||
| Immunosuppressive drugs | 3 (1.004–9.047) | 0.042 | 3.684 (0.941–14.42) | 0.061 | 1.636 (0.196–3.659) | 0.646 | 2.974 (0.333–26.562) | 0.306 |
| Dementia | 2.022 (0.853–4.791) | 0.104 | 4.87 (1.361–17.421) | 0.008 | 13.515 (2.841–64.297) | < 0.001 | ||
| Leukemia/lymphoma | 0.611 (0.072–5.185) | 0.649 | 3.652 (0.404–33.006) | 0.218 | 6.639 (0.688–64.05) | 0.06 | ||